Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androtriol injection for prevention and treatment of postoperative acute ischemic stroke
CTR20192116Phase 2Completed
- Sponsor
- Guangzhou Sceptre Pharmaceutical Technology
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of androtriol in ischemic stroke, stroke, sponsored by Guangzhou Sceptre Pharmaceutical Technology. Started Sep 2020; status: completed.
02
Drugs
androtriol
03
Conditions
ischemic strokestroke
Beyond the preview
Go deeper on CTR20192116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192116.